Basit öğe kaydını göster

dc.contributor.authorAkalın, Nilgül
dc.contributor.authorKoroğlu, Mehmet
dc.contributor.authorSezikli, Selçuk
dc.contributor.authorŞentürk, Şenol
dc.contributor.authorAşık, Murat
dc.date.accessioned2020-12-19T20:17:20Z
dc.date.available2020-12-19T20:17:20Z
dc.date.issued2015
dc.identifier.citationAkalın, N., Koroğlu, M., Sezikli, S., Şentürk, Ş. & Aşık, M. (2015). Mean platelet volume measurements affecting evaluation of parameters in dialysis patients (The affective of mean platelet volume). Clinical Practice, 12(1), 17-24. http://doi.org/10.4172/clinical-practice.100084en_US
dc.identifier.issn2044-9038
dc.identifier.urihttps://doi.org/10.4172/clinical-practice.100084
dc.identifier.urihttps://hdl.handle.net/11436/4371
dc.description.abstractBackground: We aimed to show the levels of mean platelet volum and also; the existence of effects parameters was investigated on mean platelet volum levels; in patients with dialysis replasman treatment. Materials: This study was included to the control group and patients with peritoneal dialysis and patients with hemodialysis treatments and their dialysis adequate were ensured. Venous blood samples were taken from all of the cases and mean platelet volum levels, platelet, hemoglobin, insulin resistance, C- peptide and biochemical parameters were measured. Results: Insulin resistance and C-peptid levels were found higher in the control group than in the dialysis groups. Platelet levels were found significiantly higher in dialysis groups than the control group and platelet levels were determined to be higher in the peritoneal dialysis group than the patients with hemodialysis group. Mean platelet volum levels were found higher in the dialysis patient groups than the control group. No difference statistical was observed for the levels of mean platelet volum; between dialysis groups. The relationship between was not shown to the levels of mean platelet volum with other parameters; in patients with dialysis treatment. Positive correlation was found the between platelet counts with mean platelet volum; in the control group. Conclusion: We thought that the precence of end stage renal disease and dialysis therapies might cause to increase of mean platelet volum levels; in dialysis patients. This condition can be explained by the increase of atherosclerotic complication risk and inflammation risk; in dialysis patients.en_US
dc.description.sponsorshipThis study was approved by the Ethics Committee of Bakirkoy Dr. Sadi Konuk Training and Research Hospital (Grand number: 491/2014) and conducted in accordance with the principles of the Declaration of Helsinki. This study was not supported from any third party and the work was received any financial support.en_US
dc.language.isoengen_US
dc.publisherFuture Medicine Ltd.en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFemodialysisen_US
dc.subjectMean platelet volumeen_US
dc.subjectPeritoneal dialysisen_US
dc.titleMean platelet volume measurements affecting evaluation of parameters in dialysis patients (The affective of mean platelet volume)en_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorŞentürk, Şenol
dc.identifier.doi10.4172/clinical-practice.100084
dc.identifier.volume12en_US
dc.identifier.issue1en_US
dc.identifier.startpage17en_US
dc.identifier.endpage24en_US
dc.relation.journalClinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster